Safety of aprotinin in heparinized and nonheparinized patients.
Levy
Jerrold H
JH
Department of Anesthesiology, Emory Healthcare, Atlanta, GA 30322, USA. jerrold_levy@emoryhealthcare.org
D000707:Anaphylaxis / Q000139:chemically induced; D000925:Anticoagulants / Q000627:therapeutic use*; D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control; D001803:Blood Transfusion; D002648:Child; D004347:Drug Interactions; D006490:Hemostatics / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D015201:Meta-Analysis as Topic; D019637:Orthopedic Procedures; D012449:Safety
D000925:Anticoagulants; D006490:Hemostatics; D006493:Heparin; D007611:Aprotinin